Connecticut Innovations — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Rejuvenate Biorejuvenatebio.com𝕏Jun 2026
Rejuvenate Bio develops gene therapy treatments targeting the root causes of aging to address chronic diseases such as osteoarthritis, heart disease, and cancer in companion animals and humans.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(Executive Officer, Director)Daniel Oliver(Executive Officer, Director)
BoardDavid Zhu(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.